Insiders Veracyte, Inc.

Equities

VCYT

US92337F1075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
33.80 ^USD	+2.33%		+8.72%	-19.71%

Apr. 13	Jefferies Initiates Veracyte at Buy With $45 Price Target	MT
Mar. 16	Veracyte names Kevin Haas as chief development and technology officer	RE

Insiders

Mar. 16	Veracyte Appoints Kevin Haas as Chief Development and Technology Officer	MT
Mar. 16	Veracyte, Inc. Appoints Kevin Haas as Chief Development and Technology Officer, Effective March 24, 2026	CI
Mar. 06	Veracyte Insider Sold Shares Worth $1,637,594, According to a Recent SEC Filing	MT
Mar. 06	Veracyte Insider Sold Shares Worth $662,869, According to a Recent SEC Filing	MT
Mar. 04	Veracyte Insider Sold Shares Worth $485,429, According to a Recent SEC Filing	MT
Dec. 08	Veracyte Insider Sold Shares Worth $908,923, According to a Recent SEC Filing	MT
25-10-07	Veracyte Insider Sold Shares Worth $300,709, According to a Recent SEC Filing	MT
25-10-03	Veracyte Insider Sold Shares Worth $753,204, According to a Recent SEC Filing	MT
25-07-18	Champions Oncology Names Rob Brainin CEO	MT
24-11-14	Veracyte Insider Sold Shares Worth $585,663, According to a Recent SEC Filing	MT
24-09-04	Veracyte, Inc. Announces New Board Appointments	CI
24-02-13	Veracyte, Inc. Announces Retirement of John L. Bishop, A Member of the Board of Directors	CI
23-09-27	Veracyte, Inc. Appoints Phillip G. Febbo as Chief Scientific Officer and Chief Medical Officer, Effective 2, 2023	CI
23-08-08	Veracyte, Inc. Announces Resignation of Tina S. Nova as General Manager, Urological Cancers Effective September 4, 2023	CI
23-07-24	Insider Sell: Veracyte	MT
23-07-20	Insider Sell: Veracyte	MT
23-06-21	Insider Sell: Veracyte	MT
23-04-18	Insider Sell: Veracyte	MT
23-04-13	Eiger BioPharmaceuticals Names William Kachioff CFO, James Vollins General Counsel	MT
23-03-17	Insider Sell: Veracyte	MT
23-03-02	Insider Sell: Veracyte	MT
23-01-18	Insider Sell: Veracyte	MT
23-01-12	Insider Sell: Veracyte	MT
22-12-14	Veracyte, Inc. Announces Resignation of Giulia C. Kennedy as Global Chief Scientific Officer and Chief Medical Officer	CI
22-12-05	Insider Sell: Veracyte	MT